Compare OCGN & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OCGN | FBIZ |
|---|---|---|
| Founded | 2013 | 1909 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.3M | 446.0M |
| IPO Year | N/A | N/A |
| Metric | OCGN | FBIZ |
|---|---|---|
| Price | $1.56 | $54.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $7.00 | ★ $59.67 |
| AVG Volume (30 Days) | ★ 4.1M | 27.3K |
| Earning Date | 11-05-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.14% |
| EPS Growth | N/A | ★ 30.77 |
| EPS | N/A | ★ 6.07 |
| Revenue | $5,370,000.00 | ★ $158,054,000.00 |
| Revenue This Year | $35.93 | $19.24 |
| Revenue Next Year | N/A | $7.41 |
| P/E Ratio | ★ N/A | $8.93 |
| Revenue Growth | ★ 14.26 | 12.70 |
| 52 Week Low | $0.52 | $42.18 |
| 52 Week High | $1.90 | $58.41 |
| Indicator | OCGN | FBIZ |
|---|---|---|
| Relative Strength Index (RSI) | 60.75 | 52.51 |
| Support Level | $1.32 | $53.71 |
| Resistance Level | $1.65 | $55.49 |
| Average True Range (ATR) | 0.11 | 1.31 |
| MACD | 0.02 | -0.32 |
| Stochastic Oscillator | 70.45 | 40.21 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.